SCM
Suvretta Capital Management Portfolio holdings
AUM
$3.3B
1-Year Est. Return
34.1%
1 Year Est. Return
+34.1%
AUM
$3.3B
AUM Growth
+$644M
(+24%)
Holding
106
Top Buys
| 1 | +$40.1M | |
| 2 | +$34.3M | |
| 3 | +$32.7M | |
| 4 |
Salesforce
CRM
|
+$29.7M |
| 5 |
Home Depot
HD
|
+$27M |
Top Sells
| 1 | +$87.2M | |
| 2 | +$39.4M | |
| 3 | +$29.4M | |
| 4 |
Datadog
DDOG
|
+$24M |
| 5 |
Arcutis Biotherapeutics
ARQT
|
+$19.9M |
Sector Composition
| 1 | Healthcare | 60.44% |
| 2 | Technology | 13.51% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVLA
26
Palvella Therapeutics
PVLA
$1.11B
| $51.6M | 1.32% |
822,400
+107,937
|
|
||
27
Capital One
COF
$146B
| $50.8M | 1.3% |
238,770
+44,610
|
|
||
28
Danaher
DHR
$160B
| $50.7M | 1.3% |
255,800
+81,100
|
|
||
29
Arcus Biosciences
RCUS
$3.13B
| $50.2M | 1.28% |
3,688,858
|
|
||
30
Fulcrum Therapeutics
FULC
$481M
| $49.5M | 1.27% |
5,381,000
+298,100
|
|
||
31
Compass Therapeutics
CMPX
$992M
| $49.4M | 1.26% |
14,101,159
+6,951,666
|
|
||
32
Amazon
AMZN
$2.45T
| $48M | 1.23% |
218,547
-39,078
|
|
||
33
Tesla
TSLA
$1.51T
| $40.6M | 1.04% |
91,252
-1,105
|
|
||
34
Keurig Dr Pepper
KDP
$38.7B
| $40.1M | 1.03% |
+1,570,000
|
|
||
35
Boston Scientific
BSX
$145B
| $34.5M | 0.88% |
353,561
|
|
||
36
AdvisorShares Pure US Cannabis ETF
MSOS
$724M
| $34.3M | 0.88% |
+7,167,000
|
|
||
37
UnitedHealth
UNH
$302B
| $33.2M | 0.85% |
96,220
+28,220
|
|
||
38
Avidity Biosciences
RNA
$10.8B
| $32.7M | 0.84% |
+750,000
|
|
||
39
Erasca
ERAS
$916M
| $31.6M | 0.81% |
14,502,004
|
|
||
40
Insmed
INSM
$43.7B
| $31.4M | 0.8% |
217,783
-21,000
|
|
||
41
ProKidney
PROK
$365M
| $29.9M | 0.76% |
12,341,266
|
|
||
|
42
Salesforce
CRM
$236B
| $29.7M | 0.76% |
+125,250
|
|
||
43
Dick's Sporting Goods
DKS
$20.3B
| $28.5M | 0.73% |
128,290
-132,175
|
|
||
44
Aura Biosciences
AURA
$410M
| $27M | 0.69% |
4,372,884
|
|
||
45
Monte Rosa Therapeutics
GLUE
$1.12B
| $24.9M | 0.64% |
3,360,000
|
|
||
46
Johnson & Johnson
JNJ
$488B
| $24.6M | 0.63% |
132,786
|
|
||
47
Zura Bio
ZURA
$252M
| $23.7M | 0.61% |
5,472,891
+611,952
|
|
||
48
Biogen
BIIB
$26.7B
| $23.6M | 0.6% |
168,190
+16,300
|
|
||
49
Marvell Technology
MRVL
$84.1B
| $22.9M | 0.59% |
+272,300
|
|
||
50
ServiceNow
NOW
$174B
| $20.2M | 0.52% |
+22,000
|
|